Anti-Human APP Therapeutic Antibody (2B3)
The anti-APP antibody specifically binds amyloid precursor protein from which the β-amyloid is cleaved. By binding the APP and therefore reducing the accumulation or the release of β-amyloid, the antibody can be used in the treatment of conditions related with elevated levels of β-amyloid, such as Alzheimer's Disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0847CLV |
| Pricing | Inquiry |
| Applications | WB, ELISA |
| Host | Mouse |
| Target | Amyloid precursor protein |